The National Institutes of Mental Health (NIMH) released a free video to promote awareness of the symptoms of depression and its potential treatments. In fact, they encourage public distribution of this video at schools, workshops, and other public functions. Preteen or adolescent males and females are the targeted audience. Cognitive Behavioral Therapy (CBT), psychotropic, and combined treatments are advoc ...

Today's "NIH/NIMH Research News Update" can be best described as brief yet very important. There is new information about the use of stimulant medication for ADHD and sudden death in children, cognitive therapy for depression to help at risk teens, Citalopram is no better than placebo in children with Autism, and the search to identify suicide risk factors for persons receiving anti-depressant treatment. ...

Using QEEG technology, researchers have identified a left frontotemporal dysfunction in persons who suffer from Obsessive-Compulsive Disorder, better known as OCD*. Persons with OCD have disturbing recurrent thoughts, as well as compulsive behaviors that are difficult to suppress and provide temporary relief from anxiety. The authors note that previous research has generally suggested a frontal lobe disturb ...

Keeping up with the latest research on mental health medications and their side effects can be a difficult proposition for psychologists since in most states they are not allowed to prescribe. The National Institute of Mental Health recently released a "Mental Health Medications" as a free 30 page PDF e-book. The e-book is clearly written and organized with coverage of medications for major depression, schi ...

I want to introduce a new topic to our readers. I regularly track several key websites who publish fairly constant news updates about important ongoing mental health scientific research. Due to this volume, key stories are significantly delayed or never written about here. Hence, I have created a new section entitled, "NIH/NIMH Research News Update" that will be regularly updated. The Behavioral Medicine Re ...

Autism Speaks and the Autism Clinical Trials Network report that a new low dose, melt-in-your-mouth version of Fluoxetine failed to reduce repetitive behaviors in children and adolescents diagnosed with Autism. Physicians' clinical observations that Fluoxetine controlled these behaviors spurred this research. Fluoxetine is selective serotonin reuptake inhibitor (SSRI) that is commonly referred to as a "anti ...

No better way to kick off a new research website than with controversial research. Let's start first with the concept of a "placebo effect." The placebo effect is very common in most forms of healthcare. When people who are ill (mentally or physically) believe that they will get better - guess what - they do. These are real changes though the placebo effect may wear off over time. ...